A 64-year-old Japanese man with renal dysfunction caused by autosomal dominant polycystic kidney disease (ADPKD) was admitted to our hospital for evaluation of right back pain, fever, inflammation, and pleural effusion. Diagnostic investigations for tuberculous pleuritis were all negative. Although no radiographic abnormality suggesting hepatic cyst infection was detected by computed tomography, hepatic cyst drainage demonstrated purulent contents indicative of cyst infection. Conglutination of the cyst by minocycline 100 mg was performed five times in addition to drainage. After drainage, the symptoms of inflammation, right back pain and right pleural effusion subsided. Renal function and anemia, which had been resistant to darbepoetin treatment, also improved after the procedure. These results suggested that the infected hepatic cyst was associated with the patient's symptoms, exacerbation of renal dysfunction and anemia. The pleural effusion was due to the propagation of inflammation from the cyst infection. This is the first report of an infected hepatic cyst in an ADPKD patient presenting with and diagnosed by right pleural effusion.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent inherited renal cystic disease. In affected patients, a large number of cysts in both kidneys gradually grow with age due to PKD gene mutations (1) . The cysts damage the kidneys in addition to other organs. Most cases are asymptomatic. In half of all patients, the development and growth of cysts result in early renal functional abnormalities and end-stage renal disease (ESRD). The prevalence of ADPKD is one per 3,000 to 7,000 individuals in Japan, and the disease is the cause of 2-3% of case of induction to dialysis among ESRD patients in Japan. The extra-renal manifestations of ADPKD include hypertension, polycystic liver disease, intracranial aneurysms, subarachnoid hemorrhage, cyst infection, cyst hemorrhage, ureteral stones, diverticular disease and cardiac manifestations such as mitral valve prolapse. Among these manifestations, cyst infection is difficult to diagnose and treat. We herein report a case of a 64-year-old Japanese man with pre-ESRD ADPKD who presented with right back pain and in whom we had difficulty identifying hepatic cyst infection. function four years prior to the current admission. At that time, an abdominal echogram demonstrated multiple renal cysts in the liver and both kidneys. The largest cyst in the liver measured 14.7 cm. Both of the patient's two younger brothers also had renal dysfunction; one had polycystic kidney disease, and the other was on hemodialysis. His father had a history of acute myocardial infarction, and his mother had hypertension and a history of stroke. The patient was diagnosed with ADPKD, and conservative treatment for CKD was initiated. The serum creatinine (Cr) and blood urea nitrogen (BUN) levels gradually increased during the four years of follow-up at our hospital.
On admission, the patient suffered from fatigue and right back pain radiating to the right shoulder, which became worse during inhalation. He did not have any respiratory symptoms such as dyspnea, coughing, sputum production or oxygen desaturation, prior to admission. His anemia had worsened, with a hemoglobin (Hb) level decreasing from 9-11 g/dL to 7-8 g/dL one month prior to admission despite the administration of a higher dose of darbepoetin. His blood pressure was 98/56 mmHg, his pulse rate was 91 beats per minute and his body temperature was 36.9°C. A physical examination revealed anemia in the palpebral conjunctiva and pressure pain in the right back. The findings of the chest, heart, abdomen and extremities were unremarkable. The laboratory results were as follows: serum Cr 7.67 mg/dL, BUN 70 mg/dL, estimated glomerular filtration rate (eGFR) 6.3 mL/min/1.73 m 2 , Hb 7.1 g/dL, white blood cell count (WBC) 10,070/μL (stab cells 0.5%, segmented neutrophils 91.0%, lymphocytes 3.5%, eosinophils 2.5%, basophils 0.5%, monocytes 2.0%), C-reactive protein (CRP) 10.12 mg/ dL, ferritin 515 ng/mL, asparate aminotransferase (AST) 12 IU/L, alanine aminotransferase (ALT) 10 IU/L, alkaline phosphatase (ALP) 411 IU/L and γ-glutamyl transpeptidase 100 IU/L. A urinalysis was 2 + for proteinuria and -for occult blood according to a dipstick test. A chest X-ray showed elevation of the right diaphragm (Fig. 1 ). Chest and abdominal computed tomography (CT) revealed pleural fluid and atelectasis in the right lower back thorax (Fig. 2, 3) , numerous cysts in both kidneys, gallstones and an enormous liver cyst measuring 16.9 cm in diameter. No radiographic abnormalities indicative of cyst infection were detected. The patient's back pain was controlled with sulindac, a nonsteroidal anti-inflammatory drug (NSAID). Because we considered that the back pain was due to right pleuritis, we suspected a diagnosis of tuberculous pleuritis. It is known that tuberculosis often presents with insidious and nonspecific symptoms in predialysis CKD patients, and its localization is often extrapulmonary. However, sputum microscopy, a tuberculin skin test and Interferon-Gamma Release Assay (IGRA) [QuantiFERRON-TB2G (Cellestis Ltd., Australia)] all showed negative results, excluding the presence of tuberculosis. We initiated treatment with antibiotics as empiric therapy for suspected bacterial pleuritis. As to the choice of antibiotics, we first chose ceftriaxone (CTRX) considering the possibility of Streptococcus pneumoniae, Haemophilus influenzae or Klebsiella pneumoniae as the causative bacteria and the long half-life of the drug. After treatment, there were signs of debris and gallstones in the gallbladder which suggested side effects of CTRX. Consequently, we changed the antibiotics to piperacillin-tazobactam (PIPC/TAZ). However, elevation of the CRP level persisted. Thoracic paracentesis was performed, which revealed exudative pleural effusion. We found no evidence of malignancy, such as mesothelioma, in the pleural fluid (Table) . Next, we considered the possibility that the patient's pain was derived from infection or extension of the hepatic membrane due to the enormous liver cyst. Percutaneous transhepatic drainage was performed under abdominal ultrasonographic guidance. A total of 4,680 mL of purulent fluid was drained, which indicated infection of the hepatic cyst. Five repetitions of conglutination with minocycline (MINO) were performed (2) . No pathogens were isolated from the drainage fluid. The patient's pain and inflammation gradually subsided after drainage. His renal function and anemia, which had been resistant to darbepoetin, also improved in accordance with the disappearance of inflammation (Fig. 4, 5) . 
Discussion
We herein described the diagnosis of an infected hepatic cyst in an ADPKD patient presenting with right pleural effusion. We first considered which site was the primary site of infection, the area of pleuritis or the hepatic cyst, and how the inflammation was able to spread from the primary site. Although the patient had a prior history of pneumothorax, the condition had occurred only once and had not recurred or become exacerbated before admission. There were no structural changes in the pleura indicative of inflammation. In addition, there were no findings suggestive of any association between the past episode pneumothorax and the present instance of pleuritis. We found no evidence of findings such as hypertrophy of the bronchial wall or infiltration in the lung fields on chest CT indicating a lower respiratory infection, such as bronchitis or pneumonia. The possibility of tuberculosis was also excluded based on the results of the sputum culture, tuberculin test and IGRA, as well as the contents of the pleural effusion. We did not detect any findings suggestive of carcinoma or collagen disease, as other possible causes of pleuritis. These results suggested that the pleuritis was not the primary focus of an infection occurring prior to the development of the infected hepatic cyst. Indeed, the pleural effusion subsided shortly after drainage of the hepatic cyst, accompanied by an improvement in the inflammation. Therefore, we concluded that the pleuritis was a secondary finding following the development of the infected hepatic cyst. Anatomically, the pars affixa, a region of the right lobe of the liver, makes direct contact with the diaphragm. In the present case, inflammation of the infected hepatic cyst in the right lobe of the liver may have spread to the diaphragm via the pars affixa, thereby reaching the visceral pleura. Indeed, there is a report that in cases of surgically proven liver hydatid cysts, patients with infected cysts have a greater incidence of right pleural effusion on chest X-ray examination (3). We speculate that the pleural effusion resulted from a similar process of inflammation. This case is remarkable in that the patient's condition dramatically improved after hepatic cyst drainage. Following drainage, the patient's low back pain subsided, followed by a rapid decrease in the level of CRP. The patient's anemia also improved in accordance with the disappearance of inflammation, suggesting that inflammation due to infection of the hepatic cyst was the cause of the patient's erythropoiesis stimulating agent (ESA) resistance. In addition to these changes, his renal function improved following the resolution of inflammation. Therefore, the drainage greatly contributed to improving the patient's symptoms, renal function and anemia.
Liver cysts are present in approximately 80% of ADPKD patients (80% men and 80-90% women), representing the most common extrarenal manifestation of ADPKD. The number and volume of cysts gradually increase with age. Risk factors for cyst growth include age, a female sex and the renal cyst volume. In addition, the severity of renal cystic disease, prior pregnancy, and estrogen use predict an increase in polycystic liver size in ADPKD patients (4) . Polycystic liver cysts are often benign lesions that are usually asymptomatic and require no treatment. However, cyst infection and hemorrhage can sometimes cause acute abdominal and back pain. Severe abdominal distension, tachypnea resulting from elevation of the diaphragm, nutritional disorders due to intestinal obstruction, jaundice and portal hypertension induced by pressure on the biliary ducts and portal vein can also occur.
In general, infection of a hepatic cyst may be caused by infection of a biliary duct, transportal or blood-stream infection and/or direct infection from an adjacent organ. However, there is no evidence as to where the hepatic cyst infection may originate in ADPKD patients. In the present case, infection via a biliary duct was suspected; however, no passageway was detected between the liver cysts and the ducts.
The size of the cyst may suggest infection. Although hepatic cysts are filled with fluid, of which the volume can vary from a few milliliters to several liters, a cyst with a diameter of 16.8 cm is usually considered too large to be a simple cyst. The primary indications for aspiration sclerotherapy of liver cysts are the size of the lesions and the patient's symptoms. Ishii et al. (2) recommended the use of percutaneous transhepatic drainage under ultrasonographic guidance with the injection of sclerosing agents, which are thought to kill the secretory cells of hepatic cysts and decrease the size of the lesion. The most commonly used sclerosing agent is ethanol; however, minocycline and tetracycline are also sometimes administered. The latter agents destroy the cyst wall by inducing a low pH in the cyst (4). Infected hepatic cysts with a diameter of >5 cm are good candidates for therapy (4) and require early drainage, as the administration of antibiotics alone is usually unable to cure the infection (5) . In the present patient, the diameter of the infected hepatic cyst was appoximately 17 cm; therefore, drainage was necessary.
We found no previous case reports of infected hepatic cysts in ADPKD patients presenting with and diagnosed based on right pleural effusion with back pain and inflammation. Diagnosing an infected hepatic cyst is difficult. Previous studies have suggested the level of carbohydrate antigen 19-9 (CA19-9) (6) and the results of diffusion-weighted magnetic resonance imaging (DWMRI) (7) or 18 fluorodeoxyglucose ( 18 FDG) positron-emission computed tomography (PET/CT) (8) to be markers of hepatic cyst infection. Kanaan et al. (6) reported that the serum CA19-9 levels are markedly increased during liver cyst infection in kidney transplant recipients with ADPKD. Katano et al. (7) showed that infected hepatic cysts exhibit higher signal intensity than other cysts on DWMRI. Infected cysts also demonstrate markedly decreased apparent diffusion coefficient (ADC) values compared with those of normal cysts. Katano et al. (7) reported that DWMRI is very effective in detecting infected cysts. Jouret et al. (7) reported that PET/CT is useful for confirming, locating and identifying cyst infection according to the level of 18 FDG uptake. Consequently, when ADPKD patients present with fever of unknown origin, back pain and continuous inflammation of a long duration, physicians should perform a work-up for both hepatic cyst infection and renal cyst infection. In addition, the CA19-9 level and results of DWMRI and PET/CT may be helpful for making a diagnosis.
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